Literature DB >> 33803341

A New Rise of Non-Human Primate Models of Synucleinopathies.

Margaux Teil1, Marie-Laure Arotcarena1, Benjamin Dehay1.   

Abstract

Synucleinopathies are neurodegenerative diseases characterized by the presence of α-synuclein-positive intracytoplasmic inclusions in the central nervous system. Multiple experimental models have been extensively used to understand better the mechanisms involved in the pathogenesis of synucleinopathy. Non-human primate (NHP) models are of interest in neurodegenerative diseases as they constitute the highest relevant preclinical model in translational research. They also contribute to bringing new insights into synucleinopathy's pathogenicity and help in the quest and validation of therapeutical strategies. Here, we reviewed the different NHP models that have recapitulated key characteristics of synucleinopathy, and we aimed to highlight the contribution of NHP in mechanistic and translational approaches for synucleinopathies.

Entities:  

Keywords:  animal model; neurodegeneration; non-human primates; synucleinopathy; α-synuclein

Year:  2021        PMID: 33803341      PMCID: PMC7999604          DOI: 10.3390/biomedicines9030272

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  74 in total

Review 1.  In vivo models of alpha-synuclein transmission and propagation.

Authors:  Ariadna Recasens; Ayse Ulusoy; Philipp J Kahle; Donato A Di Monte; Benjamin Dehay
Journal:  Cell Tissue Res       Date:  2017-11-29       Impact factor: 5.249

2.  Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.

Authors:  Fares Bassil; Paul A Guerin; Nathalie Dutheil; Qin Li; Matthias Klugmann; Wassilios G Meissner; Erwan Bezard; Pierre-Olivier Fernagut
Journal:  Mov Disord       Date:  2017-05-29       Impact factor: 10.338

Review 3.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

4.  Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.

Authors:  M T Herrero; E C Hirsch; A Kastner; M R Luquin; F Javoy-Agid; L M Gonzalo; J A Obeso; Y Agid
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

5.  Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.

Authors:  Kelvin C Luk; Cheng Song; Patrick O'Brien; Anna Stieber; Jonathan R Branch; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

Review 6.  α-Synucleinopathy phenotypes.

Authors:  Heather McCann; Claire H Stevens; Heidi Cartwright; Glenda M Halliday
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

7.  Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys.

Authors:  Alison L McCormack; Sally K Mak; Maryam Shenasa; William J Langston; Lysia S Forno; Donato A Di Monte
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

Review 8.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

9.  Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.

Authors:  Ronald J Mandel; David J Marmion; Deniz Kirik; Yaping Chu; Clifford Heindel; Thomas McCown; Steven J Gray; Jeffrey H Kordower
Journal:  Acta Neuropathol Commun       Date:  2017-06-16       Impact factor: 7.801

10.  CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys.

Authors:  Weili Yang; Yunbo Liu; Zhuchi Tu; Chong Xiao; Sen Yan; Xishan Ma; Xiangyu Guo; Xiusheng Chen; Peng Yin; Zhengyi Yang; Su Yang; Tianzi Jiang; Shihua Li; Chuan Qin; Xiao-Jiang Li
Journal:  Cell Res       Date:  2019-02-15       Impact factor: 25.617

View more
  2 in total

Review 1.  Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

Authors:  Tiziana Bonifacino; Roberta Arianna Zerbo; Matilde Balbi; Carola Torazza; Giulia Frumento; Ernesto Fedele; Giambattista Bonanno; Marco Milanese
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

Review 2.  Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Luis F González; Lorenzo E Bevilacqua; Rodrigo Naves
Journal:  Pharmaceutics       Date:  2021-12-01       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.